← SageRanks

Greenblatt on the GRANOLAS

This ranking weighs EV/EBITDA ×4, Return on assets ×4, and nothing else, across the 11 companies we track on the GRANOLAS. 4 of them clear Greenblatt’s hard limits right now.

Ranked highest by Greenblatt on this market right now, which is not the same list as the one that clears the limits above:

  1. Novo Nordisk (NVO) · Healthcare · EV/EBITDA 8.2 · Return on assets 18.7%
  2. GSK (GSK) · Healthcare · EV/EBITDA 8.2 · Return on assets 10.0%
  3. Roche (RHHBY) · Healthcare · EV/EBITDA 12.8 · Return on assets 13.5%
  4. Novartis (NVS) · Healthcare · EV/EBITDA 15.0 · Return on assets 10.3%
  5. Sanofi (SNY) · Healthcare · EV/EBITDA 8.0 · Return on assets 5.1%

From data as of 2026-09-11 01:00:55 UTC. Rebuilt every hour; the table above is live.

All 11 companies on the GRANOLAS, ranked by Greenblatt, as text
  1. Novo Nordisk (NVO) · EV/EBITDA 8.2 · Return on assets 18.7%
  2. GSK (GSK) · EV/EBITDA 8.2 · Return on assets 10.0%
  3. Roche (RHHBY) · EV/EBITDA 12.8 · Return on assets 13.5%
  4. Novartis (NVS) · EV/EBITDA 15.0 · Return on assets 10.3%
  5. Sanofi (SNY) · EV/EBITDA 8.0 · Return on assets 5.1%
  6. ASML (ASML) · EV/EBITDA 41.6 · Return on assets 16.4%
  7. LVMH (LVMUY) · EV/EBITDA 11.8 · Return on assets 7.7%
  8. AstraZeneca (AZN) · EV/EBITDA 14.1 · Return on assets 8.0%
  9. SAP (SAP) · EV/EBITDA 18.0 · Return on assets 9.5%
  10. L'Oréal (LRLCY) · EV/EBITDA 20.9 · Return on assets 9.5%
  11. Nestlé (NSRGY) · EV/EBITDA 15.6 · Return on assets 6.7%